Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May:53:36-48.
doi: 10.1016/j.nbd.2012.11.013. Epub 2012 Nov 29.

Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia

Affiliations
Review

Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia

Melis Inan et al. Neurobiol Dis. 2013 May.

Abstract

GABAergic interneurons of the cerebral cortex (cINs) play crucial roles in many aspects of cortical function. The diverse types of cINs are classified into subgroups according to their morphology, intrinsic physiology, neurochemical markers and synaptic targeting. Recent advances in mouse genetics, imaging and electrophysiology techniques have greatly advanced our efforts to understand the role of normal cIN function and its dysfunction in neuropsychiatric disorders. In schizophrenia (SCZ), a wealth of data suggests that cIN function is perturbed, and that interneuron dysfunction may underlie key symptoms of the disease. In this review, we discuss the link between cINs and SCZ, focusing on the evidence for GABAergic signaling deficits from both SCZ patients and mouse models.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic depicting a simplified cortical circuit (A) and some of the cortical interneuron (cIN)-related changes that are reported in SCZ patients (B). Sst, PV, GAD67 and GAT1 expression are reduced in SCZ patients. Postmortem studies reveal an increase in GABAA 2 receptors at chandelier cell synapses onto pyramidal cells (1), a decrease in GABAA 1 receptors at basket cell synapses onto pyramidal cells (2), and a decrease of NMDA receptors (NR2A subunit, in particular) at excitatory synapses onto PV+ cINs (3). Although only pyramidal synapses onto basket cells are shown, the reduction of NMDA receptors may also occur at synapses onto chandelier cells.

Similar articles

Cited by

References

    1. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE, Jr, Jones EG. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics [see comments] Archives of General Psychiatry. 1995;52:258–266. discussion 267–278. - PubMed
    1. Arion D, Lewis DA. Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia. Archives of general psychiatry. 2011;68:21–31. - PMC - PubMed
    1. Arnaiz-Cot JJ, Gonzalez JC, Sobrado M, Baldelli P, Carbone E, Gandia L, Garcia AG, Hernandez-Guijo JM. Allosteric modulation of alpha 7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission. Eur J Neurosci. 2008;27:1097–1110. - PubMed
    1. Ascoli GA, Alonso-Nanclares L, Anderson SA, Barrionuevo G, Benavides-Piccione R, Burkhalter A, Buzsaki G, Cauli B, Defelipe J, Fairen A, Feldmeyer D, Fishell G, Fregnac Y, Freund TF, Gardner D, Gardner EP, Goldberg JH, Helmstaedter M, Hestrin S, Karube F, Kisvarday ZF, Lambolez B, Lewis DA, Marin O, Markram H, Munoz A, Packer A, Petersen CC, Rockland KS, Rossier J, Rudy B, Somogyi P, Staiger JF, Tamas G, Thomson AM, Toledo-Rodriguez M, Wang Y, West DC, Yuste R. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci. 2008;9:557–568. - PMC - PubMed
    1. Ayhan Y, Abazyan B, Nomura J, Kim R, Ladenheim B, Krasnova IN, Sawa A, Margolis RL, Cadet JL, Mori S, Vogel MW, Ross CA, Pletnikov MV. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Molecular psychiatry. 2011;16:293–306. - PMC - PubMed

Publication types

Substances